about
Kappa opioids as potential treatments for stimulant dependenceRedefining the structure-activity relationships of 2,6-methano-3-benzazocines. Part 6: Opioid receptor binding properties of cyclic variants of 8-carboxamidocyclazocineEffects of kappa opioid agonists alone and in combination with cocaine on heart rate and blood pressure in conscious squirrel monkeys.Redefining the structure-activity relationships of 2,6-methano-3-benzazocines. 5. Opioid receptor binding properties of N-((4'-phenyl)-phenethyl) analogues of 8-CACPharmacological Properties of Bivalent Ligands Containing Butorphan Linked to Nalbuphine, Naltrexone, and Naloxone at μ, δ, and κ Opioid ReceptorsBi- or multifunctional opioid peptide drugs.Opioid and cocaine combined effect on cocaine-induced changes in HPA and HPG axes hormones in men.The role of kappa-opioid receptor activation in mediating antinociception and addiction.Effects of the mixed mu/kappa opioid nalbuphine on cocaine-induced changes in subjective and cardiovascular responses in men.Pharmacotherapy of addictions.The opioid receptors as targets for drug abuse medicationRedefining the structure-activity relationships of 2,6-methano-3-benzazocines. Part 8. High affinity ligands for opioid receptors in the picomolar Ki range: oxygenated N-(2-[1,1'-biphenyl]-4-ylethyl) analogues of 8-CAC.Mu opioids and their receptors: evolution of a concept.The 2-methoxy methyl analogue of salvinorin A attenuates cocaine-induced drug seeking and sucrose reinforcements in rats.Pharmacological Profiles of Oligomerized μ-Opioid Receptors."Pruning of biomolecules and natural products (PBNP)": an innovative paradigm in drug discovery.Pharmacological characterization of ATPM [(-)-3-aminothiazolo[5,4-b]-N-cyclopropylmethylmorphinan hydrochloride], a novel mixed kappa-agonist and mu-agonist/-antagonist that attenuates morphine antinociceptive tolerance and heroin self-administratioAminothiazolomorphinans with mixed κ and μ opioid activity.Redefining the structure-activity relationships of 2,6-methano-3-benzazocines. Part 9: Synthesis, characterization and molecular modeling of pyridinyl isosteres of N-BPE-8-CAC (1), a high affinity ligand for opioid receptors.[6,7]-heterocycle-fused 14-hydroxymorphinan derivatives: design, synthesis, and opioid receptor activity.Identification of novel hits as highly prospective dual agonists for mu and kappa opioid receptors: an integrated in silico approach.Effects of mixed-action kappa/mu opioids on cocaine self-administration and cocaine discrimination by rhesus monkeys.The anxiolytic- and antidepressant-like effects of ATPM-ET, a novel κ agonist and μ partial agonist, in mice.
P2860
Q24647849-22F38FD2-BED6-40A0-8E70-07E01A9D0D4EQ24649332-A660377B-8D6F-40AF-9392-38C153939931Q24676597-52DC2D55-5147-4B8F-9544-C8540381DD94Q24680272-784D2D1E-EA06-424B-BF7F-880F08B56AAFQ29542291-3C4E8F26-54A4-4BE7-A2DE-7B3885D589E5Q33767037-A2001F1B-51A4-40A1-B33D-E98B1DAC278EQ33845713-6B6122C2-9FFD-4211-B1BD-1E5CEFEB181FQ34132638-F6545BF7-0A37-4DD2-A837-8933B69ECE20Q34803483-47D6E5BA-3293-4638-97E9-B39349B7D611Q34810395-747F6420-346E-4FCE-B2FD-F30DEBB32FCDQ35978068-D3740FA3-9668-42DC-B320-9CCE00B63210Q36428759-7CBE71F9-D176-4A50-987D-663B91ED065CQ37236111-38429BA8-6E49-4067-A28C-93325B1DEA75Q37507887-014F9E59-FDC0-4200-91A1-947181F3C886Q37679197-5061981A-8434-47B9-8F1B-80040A8350C4Q38475630-967AA1FB-315E-43A7-A9CE-973BC7B3AF91Q41905640-58475C90-B981-4ECB-9E55-6194494A56A2Q42038883-2FA58415-806D-488C-AB46-F9D30D5E22AEQ43224875-F2EF7E75-AADB-4DA5-BF57-527D5138AEE2Q43256896-A618622D-F2A6-4DBE-9078-ACBD5CC6B01AQ44342538-C31BE769-3422-4F1B-A533-358F6CAAB25FQ44362497-1A629768-D2A4-434E-89C3-132DDF67AC66Q47433117-7EC71415-644A-428B-999F-F6FE5C774CA9
P2860
description
1996 nî lūn-bûn
@nan
1996 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
1996 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
1996年の論文
@ja
1996年論文
@yue
1996年論文
@zh-hant
1996年論文
@zh-hk
1996年論文
@zh-mo
1996年論文
@zh-tw
1996年论文
@wuu
name
Cyclazocine revisited
@ast
Cyclazocine revisited
@en
Cyclazocine revisited
@nl
type
label
Cyclazocine revisited
@ast
Cyclazocine revisited
@en
Cyclazocine revisited
@nl
prefLabel
Cyclazocine revisited
@ast
Cyclazocine revisited
@en
Cyclazocine revisited
@nl
P2093
P2860
P356
P1476
Cyclazocine revisited
@en
P2093
P2860
P2888
P304
P356
10.1007/BF02532378
P407
P577
1996-11-01T00:00:00Z
P6179
1006991307